Venrock Adviser, LLC
NEW YORK, NY · CIK 1615982 · 13F filing filed 2025-08-14
SEC-registered investment adviser since 2014 · limited liability company
- Assets managed$4.5bn
- Staff11 · 11 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds7 (1 hedge) · $4.5bn gross assets
- Form ADV · 2026-04-28SEC adviser record
- Legal entityVENROCK ADVISER, LLC (US)
$1.3bn
reported value
+13.5% vs Q1 2025
31positions
74.6%in top 10
4 new
4 added
6 reduced
10 sold out
vs Q1 2025
Holdings, Q2 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| APOGEE THERAPEUTICS INC COM | $368.9m27.64% | Unchanged |
| OCULAR THERAPEUTIX INC OCUL | $118.4m8.88% | Unchanged |
| METSERA INC COM | $106.7m8.00% | Unchanged |
| ENLIVEN THERAPEUTICS INC ELVN | $80.8m6.05% | Unchanged |
| KALVISTA PHARMACEUTICALS INC KALV | $76.1m5.70% | Added +25.0k |
| ORIC PHARMACEUTICALS INC ORIC | $67.0m5.02% | Added +3.4m |
| VIRIDIAN THERAPEUTICS INC VRDN | $54.3m4.07% | Unchanged |
| ORUKA THERAPEUTICS INC ORKA | $46.5m3.48% | Unchanged |
| SPYRE THERAPEUTICS INC SYRE | $40.2m3.01% | Unchanged |
| PHARVARIS N V PHVS | $36.0m2.70% | Reduced -1.1m |
| COGENT BIOSCIENCES INC COGT | $34.1m2.56% | Reduced -929.0k |
| JADE BIOSCIENCES INC JBIO | $32.2m2.41% | New |
| CYTOMX THERAPEUTICS INC CTMX | $31.7m2.38% | New |
| CIDARA THERAPEUTICS INC CDTX | $31.1m2.33% | Reduced -412.4k |
| UPSTREAM BIO INC UPB | $25.2m1.89% | Unchanged |
| ERASCA INC ERAS | $22.7m1.70% | Added +1.6m |
| CRESCENT BIOPHARMA INC. CBIO | $22.4m1.68% | New |
| DYNE THERAPEUTICS INC DYN | $20.7m1.55% | Unchanged |
| SAVARA INC SVRA | $20.3m1.52% | Added +5.6m |
| DIANTHUS THERAPEUTICS INC DNTH | $18.6m1.40% | Reduced -744.4k |
| ENGENE HOLDINGS INC COM | $18.4m1.38% | Unchanged |
| ASTRIA THERAPEUTICS INC CATB | $13.2m0.99% | Unchanged |
| CULLINAN THERAPEUTICS INC CGEM | $10.4m0.78% | Unchanged |
| ABIVAX SA ABVX | $10.3m0.77% | Unchanged |
| PERCEPTIVE CAP SOLUTIONS COR FRNM | $8.0m0.60% | Unchanged |
| SEPTERNA INC SEPN | $5.7m0.43% | New |
| SURROZEN INC SRZN | $5.7m0.42% | Unchanged |
| ZURA BIO LTD ZURA | $4.9m0.36% | Reduced -391.9k |
| ARTIVA BIOTHERAPEUTICS INC ARTV | $2.4m0.18% | Unchanged |
| CASI PHARMACEUTICALS INC CASIF | $1.2m0.09% | Unchanged |
| TENAX THERAPEUTICS INC TENX | $567.7k0.04% | Reduced -109.8k |
Sold out since Q1 2025
| Security | Value then |
|---|---|
| PRAXIS PRECISION MEDICINES I PRAX | $37.5m990.0k shares |
| SOLID BIOSCIENCES INC SLDB | $9.2m2.5m shares |
| TREVI THERAPEUTICS INC TRVI | $3.9m615.5k shares |
| APPLIED THERAPEUTICS INC APLT | $2.7m5.6m shares |
| 4D MOLECULAR THERAPEUTICS IN FDMT | $2.2m677.6k shares |
| MERSANA THERAPEUTICS INC | $1.2m3.6m shares |
| CENTURY THERAPEUTICS INC IPSC | $1.2m2.5m shares |
| TENAYA THERAPEUTICS INC TNYA | $886.8k1.6m shares |
| GLYCOMIMETICS INC | $630.0k3.0m shares |
| INSTIL BIO INC TIL | $576.0k33.2k shares |